Global Cardiac Biomarker Market by Type (Brain Natriuretic Peptide or NT-proBNP, Creatine Kinase, Ischemia Modified Albumin), Location of Testing (Laboratory Testing, Point of Care Testing), Application - Forecast 2024-2030- Product Image

Sale

Global Cardiac Biomarker Market by Type (Brain Natriuretic Peptide or NT-proBNP, Creatine Kinase, Ischemia Modified Albumin), Location of Testing (Laboratory Testing, Point of Care Testing), Application - Forecast 2024-2030

Report
181 Pages
March 2024
Region: Global
360iResearch™
ID: 4989935

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Cardiac Biomarker Market size was estimated at USD 4.62 billion in 2023, USD 5.31 billion in 2024, and is expected to grow at a CAGR of 14.90% to reach USD 12.24 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Biomarker Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Biomarker Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Biomarker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co., Ltd., Johnson & Johnson Services, Inc., Olympus Corporation, PerkinElmer Inc., Quidel Corporation, Randox Laboratories Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Biomarker Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Brain Natriuretic Peptide or NT-proBNP
- Creatine Kinase
- Ischemia Modified Albumin
- Myoglobin
- Troponins
Location of Testing
- Laboratory Testing
- Point of Care Testing
Application
- Acute Coronary Syndrome
- Atherosclerosis
- Congestive Heart Failure
- Myocardial Infarction

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Cardiac Biomarker Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Biomarker Market?
What are the technology trends and regulatory frameworks in the Cardiac Biomarker Market?
What is the market share of the leading vendors in the Cardiac Biomarker Market?
Which modes and strategic moves are suitable for entering the Cardiac Biomarker Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cardiac Biomarker Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of cardiovascular diseases globally
5.1.1.2. Increasing awareness and need for early diagnosis of cardiovascular diseases
5.1.1.3. Surge in geriatric population and related heart diseases
5.1.2. Restraints
5.1.2.1. Technical issues pertinent to sample collection and storage
5.1.3. Opportunities
5.1.3.1. Emerging investment in research and development activities in cardiac biomarkers
5.1.3.2. Emerging demand for POC testing with cardiac biomarkers
5.1.4. Challenges
5.1.4.1. Concerns over regulatory and reimbursement systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cardiac Biomarker Market, by Type

6.1. Introduction
6.2. Brain Natriuretic Peptide or NT-proBNP
6.3. Creatine Kinase
6.4. Ischemia Modified Albumin
6.5. Myoglobin
6.6. Troponins

7. Cardiac Biomarker Market, by Location of Testing

7.1. Introduction
7.2. Laboratory Testing
7.3. Point of Care Testing

8. Cardiac Biomarker Market, by Application

8.1. Introduction
8.2. Acute Coronary Syndrome
8.3. Atherosclerosis
8.4. Congestive Heart Failure
8.5. Myocardial Infarction

9. Americas Cardiac Biomarker Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cardiac Biomarker Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Biomarker Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Beckman Coulter, Inc.
13.1.3. Becton, Dickinson and Company
13.1.4. bioMérieux SA
13.1.5. DiaSorin S.p.A.
13.1.6. F. Hoffmann-La Roche Ltd.
13.1.7. Guangzhou Wondfo Biotech Co., Ltd.
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Olympus Corporation
13.1.10. PerkinElmer Inc.
13.1.11. Quidel Corporation
13.1.12. Randox Laboratories Ltd.
13.1.13. Siemens Healthcare GmbH
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. Tosoh Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. CARDIAC BIOMARKER MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC BIOMARKER MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC BIOMARKER MARKET DYNAMICS
FIGURE 7. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2023 VS 2030 (%)
FIGURE 10. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CARDIAC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CARDIAC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CARDIAC BIOMARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CARDIAC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC BIOMARKER MARKET SIZE, BY BRAIN NATRIURETIC PEPTIDE OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC BIOMARKER MARKET SIZE, BY CREATINE KINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC BIOMARKER MARKET SIZE, BY ISCHEMIA MODIFIED ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC BIOMARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC BIOMARKER MARKET SIZE, BY TROPONINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC BIOMARKER MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC BIOMARKER MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC BIOMARKER MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC BIOMARKER MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC BIOMARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC BIOMARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 31. CANADA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 34. MEXICO CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CARDIAC BIOMARKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 48. CHINA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 51. INDIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 57. JAPAN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 75. THAILAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 85. DENMARK CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 88. EGYPT CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 91. FINLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 94. FRANCE CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 97. GERMANY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 103. ITALY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 112. NORWAY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 115. POLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 118. QATAR CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 130. SPAIN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 139. TURKEY CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY LOCATION OF TESTING, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM CARDIAC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CARDIAC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. CARDIAC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. CARDIAC BIOMARKER MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMérieux SA
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Guangzhou Wondfo Biotech Co., Ltd.
Johnson & Johnson Services, Inc.
Olympus Corporation
PerkinElmer Inc.
Quidel Corporation
Randox Laboratories Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Tosoh Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.31 Billion
Forecasted Market Value ( USD ) by 2030	$ 12.24 Billion
Compound Annual Growth Rate	14.9%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Forecast 2024-2030

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028

Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028